63
Participants
Start Date
July 20, 2016
Primary Completion Date
May 24, 2017
Study Completion Date
May 24, 2017
Dexmedetomidine hydrochloride
"* 45 weeks CGA to \< 6 years old: Maintenance infusion will be started at 0.2 µg/kg/h. The infusion rate will be adjusted within a range of 0.2 to 1.4 µg/kg/h according to the pediatric subject's sedative state~* 6 years old to \< 17 years old: Maintenance infusion will be started at 0.2 µg/kg/h. The infusion rate will be adjusted within a range of 0.2 to 1.0 µg/kg/h according to the pediatric subject's sedative state"
Asahikawa Medical University Hospital, Asahikawa
Hyogo Prefectural Kobe Children's Hospital, Kobe
Shikoku Medical Center for Children and Adults, Zentsujichó
Osaka Women's and Children's Hospital, Izumi
Osaka Medical College Hospital, Takatsuki
Jichi Medical University Hospital, Shimotsuke
Juntendo University Hospital, Bunkyo-ku
Tokyo Metropolitan Children's Medical Center, Fuchū
University Hospital, Kyoto Prefectural University of Medicine, Kyoto
Okayama University Hospital, Okayama
Osaka City General Hospital, Osaka
Shizuoka Children's Hospital, Shizuoka
Lead Sponsor
Collaborators (1)
Maruishi Pharmaceutical
INDUSTRY
Pfizer
INDUSTRY